NCT05444049

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

A Feasibility Study of the NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: neurescue · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.

Conditions

• Cardiac Arrest
• Cardiopulmonary Arrest
• Cardiovascular Diseases

Interventions

Type	Name	Description
DEVICE	NEURESCUE device	The balloon catheter is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body.

Timeline

• Start date: 2022-12-08
• Primary completion: 2024-09-30
• Completion: 2024-09-30
• First posted: 2022-07-05
• Last updated: 2025-10-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study